The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks

被引:64
作者
Vazquez-Arreguin, Karina [1 ]
Tantin, Dean [1 ]
机构
[1] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 2016年 / 1859卷 / 06期
基金
美国国家卫生研究院;
关键词
Oct1/POU2F1; NuRD; Jmjd1a/KDM3A; Gastric cancer; Cervical cancer; Breast cancer; Colorectal cancer; Prostate cancer; Lung adenocarcinoma; Thyroid cancer; NF-KAPPA-B; GENE-EXPRESSION SIGNATURE; BINDING-PROTEIN; POU DOMAIN; P53-INDEPENDENT INDUCTION; COORDINATE REGULATION; PROMOTER ACTIVATION; OCTAMER FACTORS; POOR-PROGNOSIS; SYNTHASE GENE;
D O I
10.1016/j.bbagrm.2016.02.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The metazoan-specific POU domain transcription factor family comprises activities underpinning developmental processes such as embryonic pluripotency and neuronal specification. Some POU family proteins efficiently bind an 8-bp DNA element known as the octamer motif. These proteins are known as Oct transcription factors. Oct1/POU2F1 is the only widely expressed POU factor. Unlike other POU factors it controls no specific developmental or organ system. Oct1 was originally described to operate at target genes associated with proliferation and immune modulation, but more recent results additionally identify targets associated with oxidative and cytotoxic stress resistance, metabolic regulation, stem cell function and other unexpected processes. Oct1 is prooncogenic in multiple contexts, and several recent reports provide broad evidence that Oct1 has prognostic and therapeutic value in multiple epithelial tumor settings. This review focuses on established and emerging roles of Oct1 in epithelial tumors, with an emphasis on mechanisms of transcription regulation by Oct1 that may underpin these findings. This article is part of a Special Issue entitled: The Oct Transcription Factor Family, edited by Dr. Dean Tantin. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:792 / 804
页数:13
相关论文
共 140 条
  • [1] OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells
    Almeida, R
    Almeida, J
    Shoshkes, M
    Mendes, N
    Mesquita, P
    Silva, E
    Van Seuningen, I
    Reis, CA
    Santos-Silva, F
    David, L
    [J]. JOURNAL OF PATHOLOGY, 2005, 207 (04) : 396 - 401
  • [2] Glucose-Based Regulation of miR-451/AMPK Signaling Depends on the OCT1 Transcription Factor
    Ansari, Khairul I.
    Ogawa, Daisuke
    Rooj, Arun K.
    Lawler, Sean E.
    Krichevsky, Anna M.
    Johnson, Mark D.
    Chiocca, E. Antonio
    Bronisz, Agnieszka
    Godlewski, Jakub
    [J]. CELL REPORTS, 2015, 11 (06): : 902 - 909
  • [3] MUTATIONAL ANALYSIS OF THE IMMUNOGLOBULIN HEAVY-CHAIN PROMOTER REGION
    BALLARD, DW
    BOTHWELL, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) : 9626 - 9630
  • [4] Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers
    Bane, Anita
    Viloria-Petit, Alicia
    Pinnaduwage, Dushanthi
    Mulligan, Anna Marie
    O'Malley, Frances P.
    Andrulis, Irene L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) : 195 - 205
  • [5] Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
    Bao, Shideng
    Wu, Qiulian
    McLendon, Roger E.
    Hao, Yueling
    Shi, Qing
    Hjelmeland, Anita B.
    Dewhirst, Mark W.
    Bigner, Darell D.
    Rich, Jeremy N.
    [J]. NATURE, 2006, 444 (7120) : 756 - 760
  • [6] Oncosecretomics coupled to bioenergetics identifies α-amino adipic acid, isoleucine and GABA as potential biomarkers of cancer: Differential expression of c-Myc, Oct1 and KLF4 coordinates metabolic changes
    Bellance, Nadege
    Pabst, Lisa
    Allen, Genevara
    Rossignol, Rodrigue
    Nagrath, Deepak
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2012, 1817 (11): : 2060 - 2071
  • [7] Transcription factors Oct-1 and C/EBPβ (CCAAT/enhancer-binding protein-β) are involved in the glutantate/nitric oxide/cyclic-guanosine 5′-monophosphate-mediated repression of gonadotropin-releasing hormone gene expression
    Belsham, DD
    Mellon, PL
    [J]. MOLECULAR ENDOCRINOLOGY, 2000, 14 (02) : 212 - 228
  • [8] An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
    Ben-Porath, Ittai
    Thomson, Matthew W.
    Carey, Vincent J.
    Ge, Ruping
    Bell, George W.
    Regev, Aviv
    Weinberg, Robert A.
    [J]. NATURE GENETICS, 2008, 40 (05) : 499 - 507
  • [9] Oct-2 forms a complex with Oct-1 on the iNOS promoter and represses transcription by interfering with recruitment of RNA PolII by Oct-1
    Bentrari, Fatima
    Chantome, Aurelie
    Knights, Andrew
    Jeannin, Jean-Francois
    Pance, Alena
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (20) : 9757 - 9765
  • [10] POU/TBP cooperativity: A mechanism for enhancer action from a distance
    Bertolino, E
    Singh, H
    [J]. MOLECULAR CELL, 2002, 10 (02) : 397 - 407